{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:12:11Z","timestamp":1790435531485,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012331","name":"LEO Fondet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1038\/jid.2015.350","type":"journal-article","created":{"date-parts":[[2015,9,9]],"date-time":"2015-09-09T10:04:52Z","timestamp":1441793092000},"page":"93-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["Risk of Multiple Sclerosis in Patients with\u00a0Psoriasis: A Danish Nationwide Cohort\u00a0Study"],"prefix":"10.1016","volume":"136","author":[{"given":"Alexander","family":"Egeberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotus","family":"Mallbris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar Hilmar","family":"Gislason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone","family":"Skov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Riis","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/JID.2015.350_bib1","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1093\/eurheartj\/ehr285","article-title":"Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study","volume":"33","author":"Ahlehoff","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1038\/JID.2015.350_bib2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s40265-013-0030-6","article-title":"Drugs in development for relapsing multiple sclerosis","volume":"73","author":"Ali","year":"2013","journal-title":"Drugs"},{"key":"10.1038\/JID.2015.350_bib3","first-page":"263","article-title":"The Danish National Hospital Register. A valuable source of data for modern health sciences","volume":"46","author":"Andersen","year":"1999","journal-title":"Danish Med Bull"},{"key":"10.1038\/JID.2015.350_bib4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjd.12670","article-title":"Psoriasis and smoking: a systematic review and meta-analysis","volume":"170","author":"Armstrong","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1038\/JID.2015.350_bib5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ana.21141","article-title":"Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1038\/JID.2015.350_bib6","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S1474-4422(06)70552-X","article-title":"Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study","volume":"5","author":"Barcellos","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1038\/JID.2015.350_bib7","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1093\/brain\/awp289","article-title":"Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis","volume":"132","author":"Brucklacher-Waldert","year":"2009","journal-title":"Brain"},{"key":"10.1038\/JID.2015.350_bib8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1212\/WNL.58.2.314","article-title":"An open-label trial of combination therapy with interferon beta\u20131a and oral methotrexate in MS","volume":"58","author":"Calabresi","year":"2002","journal-title":"Neurology"},{"key":"10.1038\/JID.2015.350_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/511051","article-title":"A\u00a0large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes","volume":"80","author":"Cargill","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1038\/JID.2015.350_bib10","first-page":"1272","article-title":"Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis","volume":"260","author":"Dobson","year":"2013","journal-title":"J\u00a0Neurol"},{"key":"10.1038\/JID.2015.350_bib11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jns.2014.01.003","article-title":"Multiple sclerosis is associated with psoriasis. A case-control study","volume":"338","author":"Fellner","year":"2014","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1038\/JID.2015.350_bib12","first-page":"445","article-title":"The Danish prescription registries","volume":"44","author":"Gaist","year":"1997","journal-title":"Danish Med Bull"},{"key":"10.1038\/JID.2015.350_bib13","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1084\/jem.20100977","article-title":"Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells","volume":"208","author":"Ghoreschi","year":"2011","journal-title":"J\u00a0Exp Med"},{"key":"10.1038\/JID.2015.350_bib14","first-page":"1","article-title":"Interleukin-17 (IL-17) inhibitors in the treatment of plaque psoriasis: a review","volume":"20","author":"Gooderham","year":"2015","journal-title":"Skin Ther Lett"},{"key":"10.1038\/JID.2015.350_bib15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1084\/jem.170.2.607","article-title":"Tumor necrosis factor identified in multiple sclerosis brain","volume":"170","author":"Hofman","year":"1989","journal-title":"J\u00a0Exp Med"},{"key":"10.1038\/JID.2015.350_bib16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/1403494810364682","article-title":"Are low Danish fertility rates explained by changes in timing of births?","volume":"38","author":"Hvidtfeldt","year":"2010","journal-title":"Scand J Public Health"},{"key":"10.1038\/JID.2015.350_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/bjd.13013","article-title":"Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR)","volume":"171","author":"Kimball","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1038\/JID.2015.350_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2310\/7750.2010.09063","article-title":"Psoriasis and multiple sclerosis: is there a link?","volume":"14","author":"Kwok","year":"2010","journal-title":"J\u00a0Cutan Med Surg"},{"key":"10.1038\/JID.2015.350_bib19","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1365-2133.2008.09005.x","article-title":"New-onset psoriasis in a patient treated with interferon beta-1a","volume":"160","author":"Lopez-Lerma","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1038\/JID.2015.350_bib20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneurol.2009.11","article-title":"Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy","volume":"66","author":"Lozeron","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1038\/JID.2015.350_bib21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/1352458514564490","article-title":"A\u00a0systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult Scleros"},{"key":"10.1038\/JID.2015.350_bib22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-0404.2011.01558.x","article-title":"Evaluating the use and limitations of the Danish National Patient Register in register-based research using an example of multiple sclerosis","volume":"125","author":"Mason","year":"2012","journal-title":"Acta Neurol Scand"},{"key":"10.1038\/JID.2015.350_bib23","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrd3794","article-title":"Targeting IL-17 and TH17 cells in chronic inflammation","volume":"11","author":"Miossec","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1038\/JID.2015.350_bib24","first-page":"119","article-title":"Psoriasis and comorbidities: links and risks","volume":"7","author":"Ni","year":"2014","journal-title":"Clin Cosmet Invest Dermatol"},{"key":"10.1038\/JID.2015.350_bib25","first-page":"129","article-title":"Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis","volume":"138","author":"Nickoloff","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1038\/JID.2015.350_bib26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/gene.2008.16","article-title":"IL23R: a susceptibility locus for celiac disease and multiple sclerosis?","volume":"9","author":"Nunez","year":"2008","journal-title":"Genes Immun"},{"key":"10.1038\/JID.2015.350_bib27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s40263-015-0239-x","article-title":"Statin treatment in multiple sclerosis: a systematic review and meta-analysis","volume":"29","author":"Pihl-Jensen","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1038\/JID.2015.350_bib28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"10.1038\/JID.2015.350_bib29","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1212\/WNL.45.6_Suppl_6.S44","article-title":"Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors","volume":"45","author":"Selmaj","year":"1995","journal-title":"Neurology"},{"key":"10.1038\/JID.2015.350_bib30","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJM199108153250704","article-title":"Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis","volume":"325","author":"Sharief","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1038\/JID.2015.350_bib31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1212\/WNL.53.3.457","article-title":"TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study","volume":"53","year":"1999","journal-title":"Neurology"},{"key":"10.1038\/JID.2015.350_bib32","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","article-title":"Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis","volume":"172","author":"Tzartos","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1038\/JID.2015.350_bib33","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15000056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15000056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T05:12:05Z","timestamp":1655529125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15000056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0022202X15000056"],"URL":"https:\/\/doi.org\/10.1038\/jid.2015.350","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Multiple Sclerosis in Patients with\u00a0Psoriasis: A Danish Nationwide Cohort\u00a0Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/JID.2015.350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}